Literature DB >> 26520014

Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes.

Hamid Ghaedi1, Milad Bastami1, Davood Zare-Abdollahi1, Behnam Alipoor2, Abolfazl Movafagh1, Reza Mirfakhraie1, Mir Davood Omrani3, Andrea Masotti4.   

Abstract

The contribution of microRNAs (miRNAs) to cancer has been extensively investigated and it became obvious that a strict regulation of miRNA-mRNA regulatory network is crucial for safeguarding cell health. Apart from the direct impact of miRNA dysregulation in cancer pathogenesis, genetic variations in miRNAs are likely to disrupt miRNA-target interaction. Indeed, many evidences suggested that SNPs within miRNA regulome are associated with the development of different hematological malignancies. However, a full catalog of SNPs within miRNAs target sites of genes relevant to hematopoiesis and hematological malignancies is still lacking. Accordingly, we aimed to systematically identify and characterize such SNPs and provide a prioritized list of most potentially disrupting SNPs. Although in the present study we did not address the functional significance of these potential disturbing variants, we believe that our compiled results will be valuable for researchers interested in determining the role of target-SNPs in the development of hematological malignancies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hematological malignancy; Leukemia; MicroRNA; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26520014     DOI: 10.1016/j.ygeno.2015.10.004

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  10 in total

1.  The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.

Authors:  B Alipoor; H Ghaedi; R Meshkani; M D Omrani; Z Sharifi; T Golmohammadi
Journal:  J Endocrinol Invest       Date:  2017-10-22       Impact factor: 4.256

Review 2.  Genetics and Epigenetics of Myelodysplastic Syndromes and Response to Drug Therapy: New Insights.

Authors:  Saeid Shahrabi; Abbas Khosravi; Mohammad Shahjahani; Fakher Rahim; Najmaldin Saki
Journal:  Oncol Rev       Date:  2016-12-14

3.  Association of MiR-149 (RS2292832) Variant with the Risk of Coronary Artery Disease.

Authors:  Maryam Ghaffarzadeh; Hamid Ghaedi; Behnam Alipoor; Mir Davood Omrani; Faranak Kazerouni; Mehrnoosh Shanaki; Afsaneh Labbaf; Hossein Pashaiefar; Ali Rahimipour
Journal:  J Med Biochem       Date:  2017-07-14       Impact factor: 3.402

4.  An in silico approach to identify and prioritize miRNAs target sites polymorphisms in colorectal cancer and obesity.

Authors:  Morteza Gholami; Marzieh Zoughi; Bagher Larijani; Mahsa M Amoli; Milad Bastami
Journal:  Cancer Med       Date:  2020-10-18       Impact factor: 4.452

5.  Effect of miR-196a2 rs11614913 Polymorphism on Cancer Susceptibility: Evidence From an Updated Meta-Analysis.

Authors:  Md Abdul Aziz; Tahmina Akter; Mohammad Safiqul Islam
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

6.  miR-29b-3p suppresses the malignant biological behaviors of AML cells via inhibiting NF-κB and JAK/STAT signaling pathways by targeting HuR.

Authors:  Yong-Jing Tang; Wei Wu; Qiao-Qian Chen; Shu-Han Liu; Zhi-Yuan Zheng; Zhao-Lei Cui; Jian-Ping Xu; Yan Xue; Dong-Hong Lin
Journal:  BMC Cancer       Date:  2022-08-20       Impact factor: 4.638

7.  Polymorphism studies on microRNA targetome of thalassemia.

Authors:  Hamid Galehdari; Seyedeh Zohreh Azarshin; Mehdi Bijanzadeh; Mohammad Shafiei
Journal:  Bioinformation       Date:  2018-05-31

Review 8.  Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins.

Authors:  Marcus Bauer; Christoforos Vaxevanis; Nadine Heimer; Haifa Kathrin Al-Ali; Nadja Jaekel; Michael Bachmann; Claudia Wickenhauser; Barbara Seliger
Journal:  Int J Mol Sci       Date:  2020-09-27       Impact factor: 5.923

9.  Association of Genetic Polymorphisms in MicroRNAs With Type 2 Diabetes Mellitus in a Chinese Population.

Authors:  Zaihan Zhu; Yanfen Zhang; Ruocen Bai; Ru Yang; Zhongyan Shan; Chunyan Ma; Jun Yang; Dandan Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-08       Impact factor: 5.555

10.  Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation.

Authors:  Jie Wang; Yun Wu; Md Nazim Uddin; Rong Chen; Jian-Ping Hao
Journal:  Pharmgenomics Pers Med       Date:  2021-07-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.